Literature DB >> 9731749

Regulation of glucose transport by angiotensin II and glucose in cultured vascular smooth muscle cells.

L A Quinn1, W D McCumbee.   

Abstract

Glucose transport in response to angiotensin II (AII) was assessed in cultured vascular smooth muscle (VSM) cells by measuring the uptake of [3H]-2-deoxyglucose, a radiolabeled non-metabolizable glucose analog. Significant stimulation occurred by 2 hr of exposure with the maximum effect being observed between 6 and 8 hr. All effects were concentration dependent with a threshold response being detected at 0.1 nM. AII-stimulated transport was blocked by saralasin, an AII receptor antagonist, indicating that AII binding to a specific receptor is required for AII to elicit the transport response. AII-stimulated transport was also blocked when cells were incubated with cycloheximide for 6 hr, suggesting that protein synthesis is required for the long-term effects of AII on glucose transport. A specific protein synthesized in response to AII stimulation was the GLUT 1 glucose transporter as assessed by western blot analysis. Inhibition of protein kinase C (PKC) by bisindolylmaleimide and staurosporine did not affect VSM responsiveness to AII, suggesting that AII is capable of stimulating glucose transport through a PKC-independent mechanism; however, VSM responsiveness to AII did appear to be dependent upon the presence of extracellular calcium. The importance of calmodulin in mediating the response of VSM cells to AII was indicated by the inhibition of AII-stimulated glucose transport when VSM cells were incubated in the presence of the calmodulin inhibitors, calmidazolium and W7. Finally, glucose uptake increased with decreasing levels of glucose in the incubation medium. This was accompanied by a corresponding decrease in the relative effectiveness of AII in stimulating glucose uptake.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731749     DOI: 10.1002/(SICI)1097-4652(199810)177:1<94::AID-JCP10>3.0.CO;2-N

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Angiotensin II-responsive element is the insulin-responsive element in the adipocyte fatty acid synthase gene: role of adipocyte determination and differentiation factor 1/sterol-regulatory-element-binding protein 1c.

Authors:  S Kim; I Dugail; M Standridge; K Claycombe; J Chun; N Moustaïd-Moussa
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

2.  Thrombin-induced glucose transport via Src-p38 MAPK pathway in vascular smooth muscle cells.

Authors:  Yasunari Kanda; Yasuhiro Watanabe
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

Review 3.  How does blood glucose control with insulin save lives in intensive care?

Authors:  Greet Van den Berghe
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

4.  Effect of angiotensin II on energetics, glucose metabolism and cytosolic NADH/NAD and NADPH/NADP redox in vascular smooth muscle.

Authors:  John T Barron; Mark F Sasse; Aisha Nair
Journal:  Mol Cell Biochem       Date:  2004-07       Impact factor: 3.396

5.  Glucose consumption of vascular cell types in culture: toward optimization of experimental conditions.

Authors:  Keiichi Torimoto; Keisuke Okuno; Ryohei Kuroda; No'Ad Shanas; Stephanie M Cicalese; Kunie Eguchi; Katherine J Elliott; Tatsuo Kawai; Cali B Corbett; Amanda M Peluzzo; Amanda K St Paul; Michael V Autieri; Rosario Scalia; Victor Rizzo; Tomoki Hashimoto; Satoru Eguchi
Journal:  Am J Physiol Cell Physiol       Date:  2021-11-24       Impact factor: 5.282

Review 6.  Glucose dysmetabolism and prognosis in critical illness.

Authors:  Chiara Lazzeri; Roberto Tarquini; Francesco Giunta; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2008-11-22       Impact factor: 3.397

7.  Angiotensin II Modulates Podocyte Glucose Transport.

Authors:  Barbara Lewko; Anna Maryn; Elzbieta Latawiec; Agnieszka Daca; Apolonia Rybczynska
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-24       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.